Editorial Board

Cell & Cellular Life Sciences Journal

Home CCLSJ Editorial Board Shrikant Mishra

Share this profile

LinkedIn Twitter / X

✓ Link copied!

SM

Shrikant Mishra

Editorial Board Member
KIIT University India Member since 2021

Biography

Shrikant Mishra is currently working as a Professor and Head, Technology and Translation Laboratory in Kiit School of Biotechnology. A student of science, with 32 years of experience in biotechnology, with 12 biotechnology derived products in regulatory filing, 6 products in clinic, with 23 patents, 32 international publications, and having three life saving products in ICU. After completing BSc. and MSc. From St. Stephen’s College, Delhi University, New Delhi, India, he pursued his doctoral studies in Biochemistry at Virginia Maryland Regional College of Veterinary Medicine, Virginia Tech, USA on TNF cytotoxicity pathway. For the post doctoral work, he worked on role of free radicals in preeclampsia(Virginia Tech), protein protein interaction in EGFR, erbB2 and cdc20 signalling(University of Maryland), cloning of putative tumor suppressor psedugene CLP and antisense in breast cancer cells (Mayo Clinic). He returned to India in 1995 and set up to head 120 scientists and associates at Biotechnology Research laboratory (BRL)USV Ltd, Mumbai to make biotechnology derived generic recombinants including hGH, PDGF-BB, Neseritide, PTH(1-34), rEK, G-CSF, PEG-G-CSF, Lucentis, and Fmoc chemistry derived modelled peptides ( eptifibatide, bivalirudine, octreotide). He is trained in molecular biology / organic chemistry /biophysics multitasking led technology development and troubleshooting for biotech drugs.

Research Interests

Limitation of Nexplanon technology Role of mesenchymal stem cells in amelioration of toxicity of anti-cancer drugs Cell therapy complications

Other Editorial Board Members

Submit Manuscript

Chat with us on WhatsApp

Welcome to Medwin Publishers. How can we help you today?